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Abstract Adult onset Still’s disease (AOSD) is a sys-
temic auto-inflammatory condition of unknown etiology,
characterized by high fever, an evanescent, salmon-pink
maculopapular skin rash, arthralgia or arthritis and leuko-
cytosis. AOSD can also present with atypical cutaneous
manifestations, such as persistent pruritic coalescent
papules or plaques and linear lesions that have highly
distinctive pathological features and are usually associated
with severe disease. Herein, we present a 31-year-old
Brazilian man with both typical Still’s rash and atypical
persistent polymorphic cutaneous manifestations associ-
ated with severe systemic inflammatory response syn-
drome. Eosinophils that are consistently lacking in the
AOSD-associated skin lesions were evident in the skin
biopsy of the persistent atypical cutaneous manifestations
and were either drug-related or AOSD-associated.
Keywords AOSD  Systemic inflammatory response
syndrome  Eosinophils  Atypical cutaneous
manifestations
Introduction
Adult onset Still’s disease (AOSD) is a systemic auto-in-
flammatory condition of unknown etiology, characterized
by intermittent spiking high fever, an evanescent, salmon-
pink or erythematous maculopapular skin rash, arthralgia
or arthritis and leukocytosis with at least 80 % neutrophils
[1]. Other common symptoms include sore throat, lym-
phadenopathy, hepatomegaly, and splenomegaly [2]. High
serum ferritin levels, elevated ESR and high CRP levels,
absent antinuclear antibody (ANA) and rheumatoid factors
(RF) are the most common laboratory findings [3, 4]. We
report a case of AOSD in a 31-year-old Brazilian man
presenting with both typical Still’s rash and atypical non-
evanescent polymorphic cutaneous manifestations.
Case presentation
A 31-year-old Brazilian male presented with high quotid-
ian fever and night sweats, non-productive cough, lower
back pain and erythematous rash for two weeks. The fever
occurred almost daily and ranged from 39 to 40 C. The
rash started from both hands and was characterized by
multiple erythematous confluent roundish macules and
papules that coalesced to form large, irregular erythema-
tous plaques (Fig. 1). The rash lasted for a few days and
then appeared with a different morphology on the flexor
surfaces of his arms as an extensive erythematous linear
urticarial eruption (Fig. 2a). Subsequently the rash
appeared on his upper and lower trunk as multiple intensely
pruritic linear urticarial streaks (Fig. 2b). Ibuprofen has
been used intermittently to alleviate back pain as well as
the fever with minimal relief. He denied any contacts with
sick individuals, insect or animal bites and his last trip was
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to Brazil 10 months ago. He has been sexually active in a
monogamous relationship.
On admission, his temperature was 39 C and a persis-
tent pigmented plaque V shaped was evident on his anterior
chest extending down the midline to the umbilicus (Fig. 3).
Further skin examination revealed a confluent salmon-pink
papular eruption on his lower back area and a persistent
pigmented plaque on the upper area of his back. Besides
mild splenomegaly and a tender right wrist, left second and
third proximal interphalangeal joints with no signs of
swelling or erythema, the rest of the physical exam was
unremarkable. Laboratory profile revealed severe neu-
trophilic leukocytosis (30,000, normal values 4800–10,800/
mcL), and a highly elevated serum ferritin levels ([10,000,
normal values 17.90–464.00 ng/mL). Autoantibodies (in-
cluding ANA, ANCA, RF and anti-CCP) were negative.
Blood cultures excluded common viral and bacterial
infections and RPR were negative. Serological tests for
Hepatitis B and C, HIV, Epstein-Barr and Cytomegalovirus
were negative. Borrelia burgdorferi, Bartonella henselae,
Rickettsia typhi, RMSF, Typhus and Parvovirus B-19
serologies were negative as well. Parasites for malaria or
Babesia microti were undetectable on peripheral blood
smear. Transthoracic echocardiogram was negative for
vegetations and computed tomography (CT) of the neck,
chest and abdomen revealed only borderline mild
splenomegaly.
The clinical and laboratory findings were consistent with
the diagnosis of AOSD according to Yamaguchi criteria
[2]. He was started on 50 mg of prednisone. After 2 weeks
of treatment, he returned to our hospital with very high
daily spiking fever up to 39.5 C, perfuse sweating,
hypotension, elevated liver enzymes and severe leukocy-
tosis with neutrophil predominance. No new skin lesions
were noted. The patient was admitted to intensive care unit
due to suspected systemic inflammatory response syn-
drome and was started on broad-spectrum antibiotics and
intravenous fluids. Since the blood cultures were negative,
antibiotics were discontinued. Anakinra 100 mg daily
subcutaneously was added to 50 mg of prednisone with
dramatic resolution of his febrile episodes. The patient was
discharged with instructions to gradually taper prednisone.
After 1 week of treatment with Anakinra and while on
40 mg of prednisone the patient remained afebrile but new
erythematous plaques appeared on lower abdominal
quadrants and a skin biopsy was performed (Fig. 4). Skin
biopsy showed a normal epidermis, with an inflammatory
infiltrate in the dermis surrounding superficial blood ves-
sels and adnexal structures, and the interstitium as well
(Fig. 5a). The inflammatory infiltrate composed of lym-
phocytes, neutrophils and eosinophils (Fig. 5b). Because of
the persistent cutaneous manifestations, the patient was
Fig. 1 Typical evanescent rash: Multiple non-pruritic confluent
erythematous macules and papules on the dorsal surface of both
hands that coalesced to form irregular erythematous plaques
Fig. 2 Atypical urticarial rash: a linear urticarial eruption on the
flexor surface of arms. b Multiple intensely pruritic linear urticarial
streaks on the upper and lower trunk
Fig. 3 Atypical persistent rash: persistent pigmented plaque V
shaped on the anterior chest extending down the midline to the
umbilicus
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advised to apply on the persistent eruptions of his chest and
abdomen triamcinolone cream 0.5 % twice daily. After
1-month follow-up, the skin rash on the above areas almost
resolved.
Discussion
Review of literature, via the PubMed search, using the
terms adult onset Still’s disease, cutaneous manifestations
and eruptions from 1985 to 2014 to retrieve data on the
diversity in clinical manifestations and histopathological
findings of polymorphic Still’s rash, was performed
(Table 1). AOSD is a rare young adult systemic autoim-
mune disorder with diverse clinical manifestations and
occasionally unwanted serious organ damage like acute
liver failure, adult respiratory distress syndrome, dissemi-
nated intravascular coagulation, and hemophagocytic syn-
drome [5–10]. Thus, early recognition of AOSD is crucial
and should be always considered in the differential diag-
nosis of a systemic inflammatory syndrome, particularly
when extensive microbiological workup is negative.
The typical skin rash of AOSD is an evanescent salmon-
pink non-pruritic or mildly pruritic maculopapular rash,
with nonspecific histologic characteristics comprised of a
superficial perivascular lymphocytic and scattered neu-
trophilic infiltrate in the upper epidermis [11–13]. The
lesions often develop on the extremities and over the trunk
during the peak of the fever and then resolve. AOSD can
also present with various atypical cutaneous manifestations
and persistent pruritic eruptions (PPEs) are common [14].
PPEs are polymorphic both in morphology and distri-
bution patterns. The more common patterns include
lichenoid, linear and dermographism-like eruptions [14],
persistent pruritic coalescent papules and plaques [15–17]
with linear pigmentation [18], dermal and mucosal hyper-
pigmentation [19], amyloidosis-like skin eruption [20],
generalized peau d’orange appearance of the skin [21],
generalized persistent erythema [22], prurigo pigmentosa-
like eruption [23, 24], vesiculopustules [25], urticaria [26,
27] and fixed papular lesions [28]. The latter are charac-
terized by atypical wheals, present for more than 24–36 h,
with symmetrical distribution [29, 30]. Pruritic lesions are
usually evident with the presence of linear dermographism
from scratching, as was evident in our patient. The most
common atypical rash manifestation in AOSD includes the
persistent pruritic coalescent papules and plaques and lin-
ear lesions [31].
In addition to the typical maculopapular evanescent
Still’s rash, our patient had also an atypical persistent
pigmented eruption manifested with different cutaneous
morphology and geographic distribution over his body. The
linear urticarial streaky and dermographism-like eruptions
on upper extremities and torso sequentially gave place to
persistent erythematous plaques on his chest and abdomen.
We believe that this type of polymorphic cutaneous erup-
tion may be a predictor of severe systemic inflammatory
disease like in our case, and could be associated with
activation of macrophages and natural killer cells in
Fig. 4 Atypical persistent pruritic eruption: edematous erythematous
plaques on lower abdominal quadrants. Stich denotes the site of skin
biopsy
Fig. 5 a Hematoxylin and eosin (H&E) stain showing periadnexal
and perivascular infiltrate of inflammatory cells surrounding blood
vessels, hair follicles and the interstitium (in between the vessels and
adnexal structures). Original magnification at 9100. b H&E stain
showing perivascular inflammatory infiltration of lymphocytes,
neutrophils and eosinophils. Original magnification at 9400
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addition with increased production of IL-2, interferon-c
and tumor necrosis factor (TNF)- a. High levels of IL-8
were demonstrated in Still’s rash and this cytokine is
considered as the inducer of the acute phase of inflamma-
tory cascade in AOSD [32]. We believe that the cutaneous
response to Anakinra was slower than the systemic one,
since the febrile episodes resolved rapidly after initiation of
Anakinra whereas the skin lesions persisted. The intro-
duction of Anakinra therapy in our patient may have
slightly exacerbated the pre-existing cutaneous lesions and
caused new ones at the initiation of the treatment probably
due to its immune modulating effects. Anakinra has been
shown to cause interstitial granulomatous drug reaction
[33, 34]. The application of topical corticosteroids facili-
tated the resolution of the cutaneous manifestations.
The histological features of persistent eruptions include
parakeratosis [35], necrotic keratinocytes in the upper
epidermis and a perivascular and interstitial inflammatory
infiltrate of lymphocytes and neutrophils in the upper- and
mid-dermis [36–39]. In urticarial lesions the histopatho-
logic findings demonstrate an intense infiltrate of mature
CD15? neutrophils between the dermal collagen bundles.
This clinicopathological entity has recently been described
as neutrophilic urticarial dermatosis (NUD) [40].
Dyskeratosis and dermal mucinosis represent distinctive
cutaneous lesions of AOSD [41, 42]. The presence of fibrin
thrombi in the small vessel with scarce inflammatory cell
infiltration, suggestive of vasculopathy [25] has also been
observed in cases of AOSD. Leukocytoclastic cutaneous
vasculitis [43, 44] with mixed cryoglobulinemia [44] in
AOSD has been described only rare in the literature.
Eosinophils that are commonly seen in drug-induced
eruption are consistently lacking in the AOSD-associated
skin lesions [14]. Perez et al. described a case of AOSD-
related persistent erythematous rash characterized by
papules and plaques in which skin biopsy revealed
perivascular infiltration of the small vessels in the dermis
by eosinophils, histiocytes and lymphocytes [45]. In our
case, the histopathology findings of the new persistent
cutaneous eruption included the presence of several
perivascular eosinophils not just in the dermis but also in
the interstitium. The eosinophilic cutaneous manifestation
could be either drug-related (i.e. antibiotics, Anakinra) or
AOSD-associated.
Treatment of AOSD has been empirical. Non-steroidal
anti-inflammatory drugs (NSAIDs), oral corticosteroids,
disease modifying anti-rheumatic drugs (DMARDs),
methotrexate (MTX), cyclosporine, azathioprine, sul-
fasalazine and minocycline have been used to treat this rare
disease. Recently effective biologic agents including TNF-
a, IL-1 and IL-6 antagonist have been used for steroid-
resistant AOSD [46]. Laskari et al. provided evidence that
Anakinra monotherapy or in combination with a DMARD,
such as MTX may be the treatment of choice for patients
with refractory Still’s disease [47]. MTX is recommended
in patients with polyarthritis and allows for steroid dose
sparing in AOSD [48]. Our patient did not respond to
corticosteroid treatment, but showed dramatic response to
initiation of Anakinra treatment.
In summary, AOSD can manifest with atypical skin
lesions that have highly distinctive but non-pathognomonic
pathological features and are usually associated with severe
disease. Still’s rash can mimic various disorders with
maculopapular, urticarial, linear and lichenoid manifesta-
tions and skin biopsy of those atypical cutaneous lesions is
strongly recommended before or during the treatment
course of AOSD because it allows rheumatologists and
pathologists to recognize those specific distinctive
histopathological characteristics and put the correct
diagnosis.
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